NCM 24 - Biopharma Day | Oxford Nanopore Technologies
Biopharma Day
Join us at our Biopharma Day, taking place following the Nanopore Community Meeting.
Realizing the potential of Oxford Nanopore sequencing in biopharma; from R&D to commercial product
Join us in-person, at the Boston Public Library, for the first Oxford Nanopore Biopharma Day, where you will hear how nanopore sequencing is transforming the biopharmaceutical landscape, from biomarker discovery to a deeper understanding of disease mechanisms.
With dedicated tracks on Research and Development and Quality Control, featuring plenary talks and panels by industry leaders, this exclusive one-day event offers unique insights and networking opportunities. Don’t miss the chance to be at the forefront of cutting-edge genomic advancements in nanopore sequencing technology within the biopharma industry!
Applications to attend this event are now open. Once your application has been reviewed, you will be informed if your place is confirmed. Please do not make any travel arrangements before your place is confirmed. For all enquiries regarding this event, please contact events@nanoporetech.com.
Key information
Date: Wednesday, September 18
Time: 9:00 am - 5:00 pm
Location: Boston Public Library
Click to view the Biopharma Day agenda
Track 1: Biopharma QC
Over the last 20 years, sequencing has become an indispensable tool for biopharma companies, contract research organisations (CROs) and contract development and manufacturing organisations (CDMOs), across the full drug development pathway, to support different applications.
The use of sequencing in Biopharma QC, in particular, continues to grow and expand into new areas in response to updates to industry regulations and guidance.
This one-day event is packed with speakers, technical product demos and panellists who will provide a diverse perspective on the use of Nanopore sequencing within Biopharma QC today, describing successes and importantly highlighting opportunities yet to be challenged. Who should attend?
- Analytical Development Leads
- Quality Control Leads
- Regulatory CMC
- Regulatory Authorities
Why attend?
Through a series of plenary talks, panel discussions and product demos we will:
- Highlight where Nanopore sequencing has already been implemented in QC environments.
- Walk through examples of our industry ready devices and analysis workflows.
Track 2: Biopharma R&D
With a dedicated track on Research and Development, featuring plenary talks and panels by pharmaceutical industry leaders, this one-day event offers unique insights and networking opportunities.
Don’t miss the chance to immerse yourself in this one-day event filled with captivating speakers, cutting-edge technical demos, and insightful panel discussions that promise to revolutionize your perspective on Nanopore sequencing in Biopharma!
Who should attend?
- Researchers and scientists in the biopharmaceutical industry looking to explore the latest advancements in how nanopore sequencing can revolutionize antibody and neoantigen discovery
- Decision-makers seeking to enhance their understanding of how nanopore sequencing can improve precision medicine initiatives
- Service providers seeking to enhance their offering
- Academics and students keen on gaining insights into the applications related to gene editing and cell and gene therapy with nanopore
Why attend?
- Gain insights into the latest advancements, case studies and real-world applications utilizing nanopore sequencing in biopharma
- Network with experts, opinion leaders, and professionals driving innovation in precision medicine
- Participate in workshops and interactive sessions to enhance skills in genomic analysis and bioinformatics
- Discover potential collaborations, partnerships, and business opportunities to accelerate R&D